4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-047560
President, R&D sold 15,000 shares at $25.00 ($375,000)
- President, R&D acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-08-24 | Option exercise | +15,000 | $4.12 | $61,800 | 104,659 | D |
| Bergstrom Donald A President, R&D | 2022-08-24 | Sale | −15,000 | $25.00 | $375,000 | 89,659 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-08-24 | Option exercise · Stock Option (Right to Buy) | −15,000 | 147,456 | D | ||
| Open-market sales · 15,000 sh · avg $25.00 · $375,000 | |||||||
Loading xslF345X03/doc4.xml…